National Pension Service’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $81.5M | Buy |
2,406,013
+112,357
| +5% | +$3.74M | 0.05% | 261 |
|
|
2026
Q1 | $69.1M | Sell |
2,293,656
-1,206,902
| -34% | -$38.8M | 0.05% | 267 |
|
|
2025
Q4 | $109M | Buy |
3,500,558
+1,427,265
| +69% | +$35.2M | 0.08% | 198 |
|
|
2025
Q3 | $41.9M | Buy |
2,073,293
+404,526
| +24% | +$7.11M | 0.03% | 349 |
|
|
2025
Q2 | $28M | Buy |
1,668,767
+13,375
| +0.8% | +$216K | 0.02% | 406 |
|
|
2025
Q1 | $25.4M | Sell |
1,655,392
-1,429,497
| -46% | -$25.5M | 0.02% | 408 |
|
|
2024
Q4 | $68M | Sell |
3,084,889
-85,751
| -3% | -$1.56M | 0.06% | 227 |
|
|
2024
Q3 | $57.1M | Buy |
3,170,640
+1,640,940
| +107% | +$28.7M | 0.06% | 283 |
|
|
2024
Q2 | $24.9M | Sell |
1,529,700
-92,678
| -6% | -$1.43M | 0.03% | 473 |
|
|
2024
Q1 | $22.9M | Buy |
1,622,378
+1,611,856
| +15,319% | +$20.3M | 0.03% | 473 |
|
|
2023
Q4 | $110K | Hold |
10,522
| – | – | ﹤0.01% | 486 |
|
|
2023
Q3 | $108K | Hold |
10,522
| – | – | ﹤0.01% | 487 |
|
|
2023
Q2 | $79.7K | Sell |
10,522
-1,258,962
| -99% | -$10.2M | ﹤0.01% | 476 |
|
|
2023
Q1 | $11.2M | Buy |
1,269,484
+1,267,316
| +58,456% | +$12.5M | 0.02% | 446 |
|
|
2022
Q4 | $19.8K | Hold |
2,168
| – | – | ﹤0.01% | 507 |
|
|
2022
Q3 | $17K | Hold |
2,168
| – | – | ﹤0.01% | 515 |
|
|
2022
Q2 | $16K | Buy |
2,168
+277
| +15% | +$2.41K | ﹤0.01% | 510 |
|
|
2022
Q1 | $18K | Hold |
1,891
| – | – | ﹤0.01% | 510 |
|
|
2021
Q4 | $15K | Hold |
1,891
| – | – | ﹤0.01% | 504 |
|
|
2021
Q3 | $18K | Sell |
1,891
-779,258
| -100% | -$7.3M | ﹤0.01% | 485 |
|
|
2021
Q2 | $7.73M | Buy |
781,149
+93,279
| +14% | +$987K | 0.01% | 448 |
|
|
2021
Q1 | $7.94M | Buy |
687,870
+393,988
| +134% | +$4.52M | 0.02% | 448 |
|
|
2020
Q4 | $2.84M | Sell |
293,882
-1,423,194
| -83% | -$13.6M | 0.01% | 446 |
|
|
2020
Q3 | $15.1M | Hold |
1,717,076
| – | – | 0.04% | 431 |
|
|
2020
Q2 | $21.2M | Buy |
+1,717,076
| New | +$19.4M | 0.06% | 363 |
|
|
2019
Q4 | – | Sell |
-1,166,208
| Closed | -$8.02M | – | 517 |
|
|
2019
Q3 | $8.02M | Buy |
1,166,208
+46,602
| +4% | +$357K | 0.03% | 430 |
|
|
2019
Q2 | $10.3M | Sell |
1,119,606
-170,057
| -13% | -$2.05M | 0.03% | 432 |
|
|
2019
Q1 | $20.2M | Buy |
1,289,663
+40,920
| +3% | +$722K | 0.08% | 302 |
|
|
2018
Q4 | $21.6M | Buy |
1,248,743
+77,469
| +7% | +$1.59M | 0.09% | 268 |
|
|
2018
Q3 | $25.2M | Buy |
1,171,274
+249,346
| +27% | +$5.79M | 0.1% | 237 |
|
|
2018
Q2 | $22.8M | Buy |
921,928
+36,706
| +4% | +$749K | 0.1% | 251 |
|
|
2018
Q1 | $15.1M | Sell |
885,222
-169,861
| -16% | -$3.32M | 0.08% | 364 |
|
|
2017
Q4 | $20M | Buy |
1,055,083
+171,940
| +19% | +$2.59M | 0.1% | 257 |
|
|
2017
Q3 | $15.2M | Buy |
883,143
+36,858
| +4% | +$829K | 0.08% | 305 |
|
|
2017
Q2 | $27.8M | Buy |
846,285
+114,247
| +16% | +$3.54M | 0.17% | 161 |
|
|
2017
Q1 | $23.9M | Buy |
732,038
+57,726
| +9% | +$1.97M | 0.16% | 161 |
|
|
2016
Q4 | $24.4M | Buy |
+674,312
| New | +$26.9M | 0.17% | 162 |
|
Other funds holding TEVA
HIIFS
PF
CI
MMH
MIFH
LIM
National Pension Service's TEVA Position: Q2 2026 in Review
National Pension Service increased its Teva Pharmaceuticals (TEVA) stake by 4.9% in Q2 2026, buying an estimated $3.74M and bringing the position to 2,406,013 shares worth $81.5M. The position accounts for 0.05% of the portfolio, ranked #261.
National Pension Service first reported a position in TEVA in Q4 2016 and has held it in 37 quarters since. The position peaked at $109M in Q4 2025. 528 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.
- National Pension Service held 2,406,013 shares of Teva Pharmaceuticals worth $81.5M as of Q2 2026.
- National Pension Service bought 112,357 Teva Pharmaceuticals shares in Q2 2026, an estimated $3.74M.
- Teva Pharmaceuticals made up 0.05% of National Pension Service's portfolio in Q2 2026, its #261 holding.
- National Pension Service first reported a position in Teva Pharmaceuticals in Q4 2016 and has held it in 37 quarters since.
- National Pension Service's Teva Pharmaceuticals position peaked at $109M in Q4 2025.
- 528 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.
Based on National Pension Service's 13F filing for Q2 2026, filed 13 Aug 2026.